Sam Brusco, Associate Editor10.24.23
Biogennix, an osteobiologics firm that makes proprietary bone graft products used in bone fusion procedures, has launched its new OsteoSPAN fiber matrix.
OsteoSPAN consists of 100% demineralized bone fibers. It’s been engineered for optimized handling, according to the company, while offering verified osteoconductive potential and an osteoconductive scaffold that supports cellular bone formation and provokes fusion. The matrix is also processed for rapid, consistent hydration and fluid retention while resisting irrigation.
OsteoSPAN is moldable and cohesive when hydrated with blood or bone marrow and expands to fit in irregular bone voids. It’s available in 1cc, 2.5cc, 5cc, and 10cc volumes.
“OsteoSPAN Fiber Matrix is Biogennix’ first allograft product,” Biogennix chief technology officer Mark Borden told the press. “We’re excited to expand our portfolio to include allografts, which will complement our comprehensive synthetic offering and allow us to access a new segment of the bone graft market.”
OsteoSPAN consists of 100% demineralized bone fibers. It’s been engineered for optimized handling, according to the company, while offering verified osteoconductive potential and an osteoconductive scaffold that supports cellular bone formation and provokes fusion. The matrix is also processed for rapid, consistent hydration and fluid retention while resisting irrigation.
OsteoSPAN is moldable and cohesive when hydrated with blood or bone marrow and expands to fit in irregular bone voids. It’s available in 1cc, 2.5cc, 5cc, and 10cc volumes.
“OsteoSPAN Fiber Matrix is Biogennix’ first allograft product,” Biogennix chief technology officer Mark Borden told the press. “We’re excited to expand our portfolio to include allografts, which will complement our comprehensive synthetic offering and allow us to access a new segment of the bone graft market.”